One of the leading causes of death in critically ill patients is sepsis, a response of the innate immune system to pathogen-associated molecular species that is manifested by evidence of systemic inflammation and, frequently, by the later sequelae of organ systems dysfunction. 1,2 The early innate immune system response to Gram-negative bacterial infection is partially replicated by in vivo administration of lipopolysaccharide (endotoxin, LPS), that induces the features of acute systemic inflammation and modest, but self-limited, hemodynamic changes. 3 Recent data have also extended the concept that the nervous system exerts an important regulatory role over the innate immune response to illness or injury. 4 The afferent limb of the vagus nerve senses peripheral Severe injury and infection are associated with autonomic dysfunction. Diminished heart rate variability (HRV) is also observed as a component of autonomic dysfunction and is induced by endotoxin administration to healthy subjects. It is established that low-dose glucocorticoid administration diminishes the systemic inflammatory manifestations of endotoxinemia but the influence of this anti-inflammatory intervention on overall autonomic dysfunction and HRV responses to endotoxin is unknown. This study was designed to assess the influence of a low-dose hydrocortisone infusion upon endotoxin-elicited systemic inflammatory responses including phenotypic features, cytokine production, and parameters of HRV. Of 19 subjects studied, nine received a continuous infusion of hydrocortisone (3 µg/kg/min continuously over 6 h) prior to intravenous administration of Escherichia coli endotoxin (2 ng/kg, CC-RE, Lot #2) while 10 healthy subjects received only the endotoxin after a 6-h period of saline control infusion. Serial determinations of vital signs, heart rate variability assessments, and cytokine levels were obtained over the subsequent 24 h. Prior cortisol infusion diminished the peak TNF-α (P < 0.01) and IL-6 (P < 0.0001) responses after endotoxin challenge, as compared to saline infusion controls and diminished the peak core temperature response to endotoxin (P < 0.01). In contrast to the influence of cortisol on the above parameters of systemic inflammation, the significant endotoxin-induced decreases in HRV time and frequency domains were not influenced by prior hydrocortisone treatment. Hence, alterations in autonomic dysfunction occur despite hydrocortisone attenuation of other traditional systemic manifestations of endotoxinemia. The maintenance or restoration of autonomic balance is not influenced by glucocorticoid administration.
INTRODUCTION
inflammation and activates the hypothalamic-pituitary-adrenal axis. It is now also evident that the efferent limb of the vagus nerve may modulate the magnitude of the pro-inflammatory response to such inflammatory challenges 4, 5 and chemically induced inflammatory responses have been found to be associated with decreased vagus nerve activity. 6 Acetylcholine (Ach) released by the efferent vagus limb binds to macrophage α-7 nicotinic receptors and attenuates the release of the pro-inflammatory mediator, tumor necrosis factor (TNF-α). Vagal autonomic dysfunction may exist when either the afferent or efferent limbs of this axis are compromised. 7 We have recently documented that transdermal application of nicotine, a known α-7 receptor agonist, diminishes some aspects of the inflammatory response in the human endotoxin challenge model 8 One measure of autonomic function, heart rate variability (HRV), is correlated with severity of illness and outcome risk across several clinical disease conditions. HRV is measured by assessing several expressions of electrocardiogram R-R interval variability, including the standard deviation of normal R-R intervals (SDNN), and various frequency-domain spectral measures, which have been used to evaluate both adaptability and autonomic balance. 9 These measures assess the amplitude of simultaneous sine-wave oscillations in R-R intervals overlaying each other at various frequencies. Oscillations at each frequency usually reflect operation of a particular modulatory reflex, as it responds to metabolic demand from both internal and external sources. HRV also reflects autonomic balance. 9 The relationship between lower-and higher-frequency sources of HRV is thought to reflect autonomic balance, and a reduction in heart rate oscillations across the entire frequency spectrum can reflect general autonomic withdrawal.
Respiratory sinus arrhythmia (RSA) is mediated by vagus nerve activity, and generally occurs in the highfrequency range of HRV (~0.15-0.4 Hz). 9 The percentage of adjacent normal heart beats that differ by > 50 ms (PNN 50 ) also is highly correlated with RSA. Whereas low-frequency HRV (~0.05-0.15 Hz) tends to reflect the combined effects of vagal and sympathetic activity as well as baroreflex influences on heart rate (perhaps βsympathetic arousal). 9 Very low frequency HRV appears to reflect thermoregulatory activity and sympathetic effects on vascular tone and the vascular tone limb of the baroreflex. 9, 10 Reduced HRV has been noted in patients with chronic cardiovascular illnesses, such as myocardial infarction and congestive heart failure, [11] [12] [13] diabetes, 14 and end-stage renal failure. 15 Over the past decade, studies have also demonstrated that decreased HRV is associated with worsened outcome in patients with acute critical illnesses, [16] [17] [18] [19] [20] including severe infection and septic shock. 21 It is also hypothesized that subjects exhibiting HRV within the normal range may be more physiologically adaptable during acute conditions of inflammatory stress. 22 Depression of HRV parameters occurs in response to LPS administration in humans. 23, 24 Although the mechanism(s) responsible for this alteration in organ homeostasis during critical illness are largely unknown, cardiorespiratory reflexes, as well as contributions from the baroreflex and angiotensin-renin systems are known contributors to this process. 9 It is presently unknown if LPS-induced acquired autonomic dysfunction and altered HRV are linked temporally or mechanistically with other endotoxin-induced inflammatory responses.
We have previously demonstrated that intravenous administration of low-dose hydrocortisone prior to LPS challenge attenuates the subsequent inflammatory mediator profile and phenotypic responses. 25 In this context, glucocorticoid therapy is proposed to act, in part, by reducing the release and activity of pro-and anti-inflammatory mediators, as well as modulating chemotactic and adhesion molecules responsible for the recruitment or activation of inflammatory cells. 26 Given the net anti-inflammatory influence on endotoxin responses elicited by antecedent intravenous glucocorticoid 25, 27, 28 or oral dexamethasone 29 administration, we hypothesized that this influence might also extend to endotoxin-induced autonomic dysfunction and altered HRV.
PATIENTS AND METHODS

Subjects
Healthy adult male (n = 12) and female (n = 7) subjects were recruited by public advertisement and screened for normal health status under the approved guidelines of the Institutional Review Board of the Robert Wood Johnson Medical School.
Inclusion criteria for the study were: good general health as demonstrated by medical history and physical examination, age 18-40 years, complete blood count and basic metabolic panel within normal laboratory limits. Exclusion criteria included history of any acute or chronic disease, arrhythmia, recent history of alcohol or drug intake, pregnancy or prior exposure to LPS in the experimental setting. Once informed, written consent was obtained, all subjects received an initial recording of heart rate and electrocardiogram (ECG) to screen for any arrhythmic patterns or irregular heart beats. Only subjects with a normal standard ECG were considered for admission to the protocol.
Study design and procedures
Upon accrual to the study, the subjects were admitted to the Clinical Research Center (CRC) at UMDNJ-Robert Wood Johnson Medical School the afternoon prior to the study and a repeat examination confirmed that no changes in health status had occurred since enrollment.
Following admission, subjects were randomized to one of two study groups: (i) those that would receive a placebo infusion of physiological saline prior to endotoxin (LPS) administration (LPS group, n = 10); and (ii) those that would receive a continuous intravenous infusion of cortisol for 6 h prior to endotoxin administration (CORT+LPS group, n = 9). Patients were fasted from midnight of the admission day and given intravenous fluids (5% dextrose and 0.45% sodium chloride) 1 ml/kg/h via a peripheral venous catheter. The treatment group received hydrocortisone (3 µg/kg/min), administered intravenously by continuous infusion for 12 h beginning at 03:00 on day 1 of the study. As previously described, a radial arterial catheter was placed (07:00) the morning of the study day. 8, 25 The arterial catheter was utilized to monitor heart rate and blood pressure as well as for periodic blood sampling at defined time points before and after endotoxin administration. A rectal thermometer was placed for continuous monitoring of core body temperature. As previously described , 8 a one-time dose of endotoxin (2 ng/kg, CC-RE, Lot #2) was administered over a 1-min period through a separate peripheral intravenous catheter at approximately 09:00 (considered time point 0) on study day 1.
Clinical monitoring
Vital signs, including heart rate and mean arterial blood pressure (MAP), were recorded every 30 min from the arterial monitoring system for the first 6 h (09:00-15:00) and then taken manually at 9, 12, and 24 h after LPS administration. Core temperatures were recorded every 30 min for 6 h via a rectal thermometer, then orally at 9, 12, and 24 h after LPS administration.
After 6 h, the arterial catheter and rectal thermometer were removed. The peripheral intravenous catheter was removed once each subject tolerated a regular diet. Subjects remained in the CRC overnight and were discharged to home the following morning after the 24-h post-LPS samples were obtained.
Assessment of heart rate variability parameters
A base-line determination of HRV was obtained at the time of admission as well as every hour (0 to +6 h) following endotoxin challenge and at +9 h and +24 h after LPS. The HRV recording interval consisted of two consecutive 5-min epochs. During HRV determinations, heart rate and respiration were monitored using a continuous electrocardiography technique with three standard leads, a respiratory belt, and CardioPro ® 2.0 software with one Infiniti and one Procomp Plus ® recorder (Thought Technology, Ltd, Montréal, Québec, Canada). HRV parameters and inter-beat intervals were collected using ECG data at a rate of 256 samples/s. The respiration channel collected respiratory data at a rate of 32 samples/s. Because movement artifact occasionally influenced computer-detected respiration rates, this measure was subsequently scored by hand. Minor fluctuations in the tracing, due either to movement or to changes in inhalation patterns during individual breaths, were not counted in tallying respiration rate.
Analysis of heart rate variability
In a continuous ECG record, each QRS complex was detected and the 'normal-to-normal' (NN) intervals (all intervals between adjacent QRS complexes resulting from sinus node depolarization) were tabulated. The WinCPRS ® program (Absolute Aliens Oy, Turku, Finland) was used to analyze respiratory parameters further and to confirm the CardioPro analysis of heart rate variability parameters. To assess overall heart rate variability, we calculated standard deviation of normal-tonormal interbeat intervals (SDNN). Sympathetic function was analyzed using very low frequency HRV (0.005-0.05 Hz rate oscillation between 0.3-3 times/min) and low frequency (0.05-0.15 Hz rate oscillation between 3-9 times/min) HRV. These measures also provided indirect measures of baroreflex gain, an element in adaptive capacity. We did not analyze high frequency HRV, the usual statistic for assessing RSA (and vagus nerve activity), because respiration rate sometimes fell outside this range during the post-LPS challenge period. Instead, we utilized the time domain statistic PNN 50 (percentage of normal-to-normal interbeat intervals > 50 ms) to assess parasympathetic function. PNN 50 reflects the occurrence of particularly large changes between adjacent heart beats, which usually occurs exclusively in response to respiration. It is correlated with high frequency HRV, and can be used as an alternative method for assessing RSA. 9 All signals were exported in standard ASCII format to Excel and EAS 9.0 for analysis and graph production. For each epoch, noise artifact was manually edited post hoc by visual inspection prior to calculation of interbeat intervals using CardioPro software. The pattern of interbeat intervals was adjusted by interpolation, estimating a missing value by averaging adjacent known values (as measured by defined R-R interval per subject). We excluded complete measurement epochs where such editing and extrasystolic or skipped heartbeats or other arrhythmias comprised greater than 10% of the total epoch. The power spectral density then was calculated using a Fast Fourier transformation algorithm. 30, 31 Spectral analysis was performed across 5-min periods within each epoch.
Analysis of blood samples
Blood samples were collected at time points -24, 0, 0.5, 1, 1.5, 2, 3, 4, 6, and 24 h in relation to endotoxin administration. Blood-derived plasma was then subjected to ELISA for measurement of soluble inflammatory markers (TNF-α, IL-6, IL-8, and IL-10) and radioimmunoassay analysis of cortisol levels, as previously described. 32
Statistical analysis
Analysis of vital signs and metabolites
We computed descriptive statistics and analyzed vital signs and soluble inflammatory mediator measures by two-way analysis of variance with repeated measures on time using Statistica v.6.1 (StatSoft, Inc., Tulsa, OK, USA). 33 P-values less than 0.05 were considered to be statistically significant. The group (CORT + LPS versus LPS alone) x time interactions are reported below for assessment of an effect of cortisol on the response to LPS.
Analysis of HRV parameters
For respiration and HRV measures, we used mixed model analyses with repeated measures using Proc Mixed from the SAS system (v.9.1). Because these measures were not always performed at exact hourly intervals during the testing day, we treated time as a continuous variable and modeled the time trend of each dependent variable with polynomials, and determined the order of degrees of polynomials by the P-values (< 0.05), residual plots and the Akaike's Information Criterion (AIC). 34 The variance-covariance structure for repeated measures, determined by the AIC was modeled with the autoregressive model (order of one) that assumes stronger correlations for measurements closer in time.
Because RSA may be affected by respiration rate independently of vagus nerve traffic, 35 we used a recommended 36 statistical control for respiration rate in all HRV analyses. However, as LPS and corticosteroid administration might independently affect both respiration rate and autonomic activity, we also analyzed HRV variables without adjusting for respiration rate.
RESULTS
Study population
All 19 subjects completed the entire study protocol. The CORT+LPS group consisted of 9 participants (4 females, 5 males) with a mean age of 19 ± 0.3 years. There were 10 subjects (3 females, 7 males) with a mean age of 25 ± 2 years in the LPS alone group.
Plasma cortisol concentrations
In the LPS alone group, plasma cortisol levels rose from 12 ± 4 µg/100 ml at baseline to peak levels of 22 ± 2 µg/100
Low-dose steroid alters in vivo endotoxin-induced systemic inflammation 361 ml after LPS administration while over the same time period cortisol concentrations increased from 15 ± 3 µg/100 ml to 41 ± 4 µg/100 after 6 h of cortisol infusion and ran in this range throughout the subsequent 6 h of infusion ( Fig. 1) .
Vital signs
The temperature response to endotoxin was significantly greater (P < 0.01) in the LPS alone group (peak 38.6 ± 0.6°C) compared to the CORT+LPS group (peak 38.0 ± Fig 2A) . The LPS alone group demonstrated a greater increase in heart rate, compared to CORT+LPS (P < 0.02; Fig. 2B ) while the MAP response to LPS was also statistically significant between groups (P < 0.03; Fig. 2C ) However, the respiratory rate after LPS did not differ between groups (Fig. 2D ).
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Inflammatory markers
An overall lower pro-inflammatory cytokine release was evident in the CORT+LPS group when compared to LPS alone. The LPS alone group displayed significantly higher (P < 0.003) levels of TNF-α than the CORT+LPS group (Fig. 3A ) and greater levels (P < 0.0001) of IL-6 were measured in the LPS alone group as compared to the CORT+LPS group (Fig. 3B ). IL-8 levels were not significantly different between the two groups (data not shown). Peak values of the anti-inflammatory cytokine IL-10 were significantly higher (P < 0.0001) in the CORT+LPS group when compared to LPS alone (Fig.  3C ). All measured inflammatory mediators returned to baseline levels by 24 h post LPS administration.
HRV and respiration
Cortisol effect
Cortisol infusion had no effect on respiration rate or any cardiac variable prior to or following the administration of LPS.
Respiration rate
Respiration rate differed significantly over time, increasing in response to LPS exposure, occasionally reaching levels > 0.4 Hz (i.e. above the level at which RSA is reflected in high frequency HRV), and then returned to baseline at 24-h post-LPS exposure (Fig. 2D; Table 1 ).
HRV measures
Because of skewed distributions, we analyzed the data of SDNN and low frequency HRV using the log transformation. Other cardiac measures were analyzed using raw values.
To assess overall autonomic withdrawal, particularly general withdrawal of autonomic modulatory reflex activity, we examined SDNN, which decreased after LPS exposure in both LPS alone and CORT+LPS groups. Because increased respiration rate can diminish the sensitivity of HRV measures to autonomic influences, 37 particularly in the respiratory frequency range, we statistically adjusted all HRV measures for respiration rate. However, because such an adjustment can potentially factor out real changes in autonomic function, we also present analyses that are uncontrolled for respiration. Overall heart rate variability was assessed using the time domain statistic SDNN, which decreased after LPS exposure in both LPS alone and CORT+LPS groups. With and without adjustments for respiration, the main effect for changes over time showed a significant linear and quadratic trend (P < 0.05 and P < 0.003, respectively), indicating that SDNN decreased significantly after LPS exposure when compared to baseline, and returned toward baseline values by 24 h (Fig. 4A; Table 1 ). These and other HRV measurements demonstrated maximum effects at 3-4 h post LPS administration.
Because respiration rate sometimes rose above the high frequency range, we estimated RSA (and hence cardiac vagal tone) by PNN 50 rather than by high frequency HRV. PNN 50 decreased after LPS exposure in both the LPS alone and CORT+LPS groups, and returned toward baseline within 24 h ( Fig. 4B ; Table 1 ). Linear and quadratic trends were significant, whether or not controlled for respiration. The analyses of very low frequency and low frequency HRV revealed the same pattern for these measures, both adjusted and not adjusted for respiration rate (Fig. 4C,D ; Table 1 ).
DISCUSSION
We have previously documented that antecedent cortisol infusion blunts the pro-inflammatory cytokine response to LPS administration while enhancing at least some anti-inflammatory responses, as reflected by increased plasma IL-10 concentrations. 25, 28 This is consistent with the long-established, generalized anti-inflammatory effects of glucocorticoids. 38, 39 A significant attenuation of systemic pro-inflammatory mediators (TNF-α and IL-6) was observed after LPS administration as has been previously documented with both hydrocortisone infusion and oral prednisolone. 25, 29 Additionally, the cortisol infused group also demonstrated enhancement of an anti-inflammatory mediator (IL-10) when compared to placebo. 27, 28 There is currently interest in identifying quantifiable, rapidly attainable measures that may be utilized to recognize 'at-risk' patients prior to the onset of inflammation-related decompensation. Measurements of HRV have shown promise as such a tool. In the clinical setting of critical illness, methods of collection and interpretation of autonomic nervous system activity with potential utility in real time have been undertaken with some success. 17, 19 Several studies have even implied the use of HRV as an additional vital sign in the assessment and care of critically ill patients with the hopes of earlier intervention for those patients deemed at higher risk based on HRV-derived parameter(s). 17, 19, 40 Norris et al. 17 have termed their analysis Cardiac Volatility Related Dysfunction (CVRD) which is derived from HRV measurements. Along similar lines, Winchell and colleagues 19 have also reported a HRV analysis in a surgical ICU setting, correlating low autonomic tone and/or lack of sympathetic tone with increased mortality. A recent article also confirms significantly altered autonomic function assessed by HRV parameters in association with increased IL-6 levels in septic patients. 41 We hypothesized that antecedent administration of low-dose steroid might alter the effects of LPS on HRV/autonomic dysfunction. The potential role of steroid therapy in severe inflammation has recently been emphasized in a large study of trauma patients exhibiting diminished HRV. 42 It was suggested that, among injured patients with diminished HRV, there exists a subset of patients with established adrenal insufficiency who, upon treatment with exogenous steroid, demonstrate both recovery of diminished HRV activity and improved clinical outcome. Hence, there does appear to be a population of severely stressed patients whose clinical conditions are responsive to steroid treatment and restoration of HRV parameters toward normal occurs in concert with overall outcome improvement.
In addition to assessing autonomic function and generalized adaptability, assessments of HRV parameters may provide a window to the balance of sympathetic and parasympathetic activity. Our data indicate that LPS exposure decreased both sympathetic and parasympathetic influences on HRV. The apparent inconsistency between decreased sympathetic activity and increased heart rate in this paper may be explained, in part, by the 'braking' function of vagus activity on heart rate, and interaction with the cardiac pacemaker. 43 Additionally, it is known that vagal oscillatory components in heart rate variability are often decoupled from vagal influences on tonic heart rate, 43, 44 and that the two correlate with activity in different vagal fibers. 45 A significant attenuation of systemic pro-inflammatory mediators (TNF-α and IL-6) was observed after LPS administration as has been previously documented with both hydrocortisone infusion and oral prednisolone. 25, 29 Additionally, the cortisol infused group also demonstrated enhancement of an anti-inflammatory mediator (IL-10) when compared to placebo. 27, 28 The temporal relationship of IL-10 appearance coincided with the time of maximal depression in HRV measures of vagal tone. Although animal studies have not demonstrated altered in vivo IL-10 responses after vagal transaction or in response to active vagus nerve stimulation, this previously unknown relationship suggests an intriguing enhancement of the anti-inflammatory IL-10 compensatory mechanism in the setting of diminished autonomic activity. 5, 6 As there were no statistically significant differences between placebo and glucocorticoid treated groups with respect to HRV parameters and autonomic balance, it is perhaps possible that a dose-dependent threshold of glucocorticoid activity was not achieved for these parameters. A dose-dependent relationship for other systemic inflammatory markers was observed in recent studies of oral prednisolone therapy in this model. 29 Whether higher doses of glucocorticoid infusion might influence autonomic dysfunction and altered HRV remains to be determined. Rather, we chose to utilize a low-dose hydrocortisone (3 µg/kg/min) regimen that is consistent with recently investigated protocols among severely infected patients. 26, 46 This dose of cortisol resulted in steady-state plasma cortisol concentrations of approximately 40-50 µg/100 ml that may not achieve the full anti-inflammatory effects of either bolus intravenous dosing or oral prednisolone. 28 The evolving concept of disrupted autonomic function under conditions of infectious challenge has been confirmed in this model and, in addition, we provide evidence of reduced vagal and sympathetic tone. However, this study found no evidence that the present steroid regimen attenuated the apparent LPS-induced reduction in parasympathetic or sympathetic tone. Interestingly, the attenuation of TNF and IL-6 production observed with glucocorticoid pretreatment was not correlated with alterations in apparent vagal activity and overall autonomic balance. This implies that low-dose steroid administration in the critical care setting is unlikely to influence outcome through a restoration or maintenance of vagal activity or overall autonomic dysfunction in the absence of adrenal insufficiency. 42 The present study also raises intriguing questions as to the influence of other endogenous or exogenous hormonal influences upon the balance of autonomic functions during stressful conditions.
CONCLUSIONS
The current results document that the inflammatory response evoked by LPS exposure causes depression of both cardiovagal and sympathetic tone and a decrease in overall HRV in a population of healthy adults. The present data are consistent with previous studies showing an association between LPS-induced inflammation and depressed cardiovagal activity. 23, 24 The development of such autonomic dysfunction is not responsive to a lowdose of glucocorticoid administration regimen that otherwise dampens systemic responses and inflammatory mediator production induced by LPS.
Based upon these findings, future studies may fruitfully examine effects of higher steroid doses, as well as other regimens influencing both sympathetic and parasympathetic activity.
